Copyright © 2004 by the European Society of Cardiology.
Editorial
In search of the grail: the never-ending story of biomarkers for coronary risk prediction
Institute of Health Studies, Barcelona, Spain
* Correspondence to: Susana Sans, Hospital de la Santa Creu i Sant Pau, Programa Cronicat, P. Claret 167, 08025 Barcelona, Spain. Tel.: +34-934563612; fax: +34-934331572
E-mail address: susana.sans@uab.es
| The first 10% of the full text of this article appears below. |
This editorial refers to "Association between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30000 individuals"1 by J.G. Wheeler et al. on page 1287
"I was brought up in an older tradition. I was told: "before ordering a test decide what you will do if it is (a) positive, or (b) negative, and if both answers are the same don't do the test. At the other end of the scale is the most recent innovation whereby a package of results of a dozen tests arrive at the bedside almost before the signs and symptoms have been elicited" A. Cochrane. Effectiveness and efficiency, p. 43.
The leukocyte has been recognised as a principal effector cell in the acute inflammatory reaction since the end of the 19th century.1 Circulating leukocytes, especially the
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30 374 individuals
- Jeremy G Wheeler, Michael E Mussolino, Richard F Gillum, and John Danesh
EHJ 2004 25: 1287-1292.[Abstract] [Full Text]